Randomized, Phase 3 Study of MK-7684A Plus Concurrent Chemoradiotherapy (cCRT) Followed by MK-7684A vs cCRT Followed by Durvalumab for Unresectable, Locally Advanced, Stage III Non-Small-Cell Lung Cancer (NSCLC): KEYVIBE-006
MK-7684A;Durvalumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Randomized, Phase 3 Study of MK-7684A Plus Concurrent Chemoradiotherapy (cCRT) Followed by MK-7684A vs cCRT Followed by Durvalumab for Unresectable, Locally Advanced, Stage III Non-Small-Cell Lung Cancer (NSCLC): KEYVIBE-006 ### Output: MK-7684A;Durvalumab